PROTEON THERAPEUTICS INC Contracts & Agreements
101 Contracts & Agreements
- Business Finance (25 contracts)
- Business Operations (26)
- Human Resources (27)
- Intellectual Property (3)
- Mergers & Acquisitions (2)
- Real Estate (3)
- Uncategorized (15)
- Subscription Agreement, dated April 5, 2024 (Filed With SEC on April 5, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 5, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on April 5, 2024)
- Registration Rights Agreement, dated April 5, 2024 (Filed With SEC on April 5, 2024)
- Separation and Consulting Agreement and Release, dated as of March 18, 2024, by and between the Company and Jathin Bandari, M.D (Filed With SEC on March 18, 2024)
- Amended and Restated Executive Employment Agreement, entered into as of June 1, 2023, by and between the Registrant and Patrick Fabbio (Filed With SEC on August 3, 2023)
- Executive Employment Agreement, effective as of January 30, 2023 by and between the Registrant and Patrick Fabbio (Filed With SEC on March 8, 2023)
- Separation Agreement and Release, dated as of June 20, 2022, by and between Blaine Davis and the Company (Filed With SEC on June 21, 2022)
- Consulting Agreement, dated as of October 16, 2021, by and between the Company and Martn Sebastian Olivo, M.D (Filed With SEC on October 18, 2021)
- Separation Agreement and Release, dated as of October 15, 2021, by and between the Company and Martn Sebastian Olivo, M.D (Filed With SEC on October 18, 2021)
- Restated Non-Employee Director Compensation Policy (Filed With SEC on May 6, 2021)
- Executive Employment Agreement, effective as of April 19, 2021, by and between the Registrant and Martn Sebastian Olivo, M.D (Filed With SEC on May 6, 2021)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 11, 2021)
- Lease by and between 345 PAS HOLDING LLC, and the Registrant, dated as of December 7, 2020 (Filed With SEC on March 11, 2021)
- Amendment to Agreement, by and between Chugai Pharmaceutical Co., Ltd. and the Registrant, dated as of July 14, 2020 and effective as of June 30, 2020 (Filed With SEC on November 12, 2020)
- Underwriting Agreement related to the Common Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
- Underwriting Agreement related to the Preferred Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
- Restated Non-Employee Director Compensation Policy (Filed With SEC on July 31, 2020)
- Separation Agreement and Release, dated as of July 23, 2020, by and between the Registrant and Julio Casoy (Filed With SEC on July 31, 2020)
- ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 20, 2020)
- Forms of Stock Option Agreement, Option Exercise, Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the Amended and Restated 2014 Equity Incentive Plan of the... (Filed With SEC on March 20, 2020)
- Executive Employment Agreement, dated as of February 6, 2020, by and between the Registrant and Julio Casoy, M.D (Filed With SEC on March 20, 2020)
- Executive Employment Agreement, effective as of February 11, 2020 by and between the Registrant and Blaine Davis (Filed With SEC on March 20, 2020)
- Restated Non-Employee Director Compensation Policy (Filed With SEC on March 20, 2020)
- Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated November 19, 2019, by and among the Registrant, ArTara Therapeutics, Inc. and REM 1 Acquisition, Inc (Filed With SEC on January 10, 2020)
- Form of Common Stock Certificate (Filed With SEC on January 10, 2020)
- Amended and Restated 2014 Equity Incentive Plan of the Registrant, as amended (Filed With SEC on January 10, 2020)
- Executive Employment Agreement, dated as of November 5, 2019, as amended on December 4, 2019, by and between ArTara Subsidiary, Inc. and Jesse Shefferman (Filed With SEC on January 10, 2020)
- Executive Employment Agreement, dated as of December 17, 2019, by and between ArTara Subsidiary, Inc. and Jacqueline Zummo, Ph.D., MPH, MBA (Filed With SEC on January 10, 2020)
- Choline License Agreement, by and between ArTara Subsidiary, Inc. and Alan L. Buchman, M.D. dated as of September 27, 2017 (Filed With SEC on January 10, 2020)
- Sponsored Research and License Agreement, by and between ArTara Subsidiary, Inc. and The University of Iowa dated as of November 28, 2018 (Filed With SEC on January 10, 2020)
- License Agreement, by and between ArTara Subsidiary, Inc. and The Feinstein Institute for Medical Research dated as of December 22, 2017 (Filed With SEC on January 10, 2020)
- Agreement, by and between ArTara Subsidiary, Inc. and Chugai Pharmaceutical Co., Ltd. dated as of June 17, 2019 (Filed With SEC on January 10, 2020)
- Form of Indemnity Agreement between the Registrant and each of its directors and officers (Filed With SEC on January 10, 2020)
- Subscription Agreement, dated September 23, 2019, by and among the Registrant and the institutional investors named therein, and the First Amendment to Subscription Agreement,... (Filed With SEC on January 10, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on January 10, 2020)
- 2017 Equity Incentive Plan of ArTara Subsidiary, Inc (Filed With SEC on January 10, 2020)
- Separation Agreement, dated December 20, 2019, by and between Proteon Therapeutics, Inc. and George A. Eldridge (Filed With SEC on December 23, 2019)
- Separation Agreement, dated September 30, 2019, by and between Proteon Therapeutics, Inc. and Timothy P. Noyes (Filed With SEC on October 2, 2019)
- Consulting Agreement, dated October 1, 2019, by and among Proteon Therapeutics, Inc., certain of Proteons subsidiaries and Timothy P. Noyes (Filed With SEC on October 2, 2019)
- Form of Support Agreement, by and among ArTara Therapeutics, Inc., Proteon Therapeutics, Inc. and certain stockholders of ArTara Therapeutics, Inc. named therein (Filed With SEC on September 24, 2019)
- Form of Support Agreement, by and among Proteon Therapeutics, Inc., ArTara Therapeutics, Inc. and certain stockholders of Proteon Therapeutics, Inc. named therein (Filed With SEC on September 24, 2019)
- Form of Lock-Up Agreement, by each of the parties named in each agreement therein (Filed With SEC on September 24, 2019)
- Subscription Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
- Registration Rights Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
- Agreement and Plan of Merger and Reorganization, dated September 23, 2019, by and among Proteon Therapeutics, Inc., REM 1 Acquisition, Inc. and ArTara Therapeutics, Inc (Filed With SEC on September 24, 2019)
- Amendment No. 3 to Manufacturing Services Agreement by and between the Company and Lonza LTD dated as of May 4, 2018 (Filed With SEC on August 7, 2018)
- Fourth Amendment to Lease by and between Proteon Therapeutics, Inc. and Boston Properties Limited Partnership, dated August 17, 2009 (Filed With SEC on November 7, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 3, 2017)
- ProteonTherapeutics, Inc. AMENDEDAND RESTATED 2014 EQUITY INCENTIVE PLAN (Filed With SEC on August 3, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- VOTING AGREEMENT (Filed With SEC on June 23, 2017)
- FIFTH AMENDED AND RESTATED INVESTORS’RIGHTS AGREEMENT (Filed With SEC on June 23, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 23, 2017)
- AMENDMENT NO. 2 To MANUFACTURING SERVICES AGREEMENT Dated 30 June 2015 Between Proteon Therapeutics, Inc. And LONZA LTD (Filed With SEC on May 9, 2016)
- Manufacturing ServicesAgreement (this “Agreement”) (Filed With SEC on November 12, 2015)
- PROTEON THERAPEUTICS,INC. $40,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on November 12, 2015)
- UNDERWRITING AGREEMENT [Number of Firm Shares] Shares Proteon Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2014)
- PROTEON THERAPEUTICS, INC. AMENDED AND RESTATED 2006 EQUITY INCENTIVE PLAN ADOPTED: AUGUST 21, 2014 APPROVED BY STOCKHOLDERS: OCTOBER 3, 2014 TERMINATION DATE: MARCH 23, 2016 (Filed With SEC on October 7, 2014)
- PROTEON THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on October 7, 2014)
- PROTEON THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 7, 2014)
- Proteon Therapeutics, Inc. 200 West St. Waltham, MA 02451 October 1, 2014 (Filed With SEC on October 7, 2014)
- Proteon Therapeutics, Inc. 200 West St. Waltham, MA 02451 October 1, 2014 (Filed With SEC on October 7, 2014)
- Proteon Therapeutics, Inc. 200 West St. Waltham, MA 02451 October 1, 2014 (Filed With SEC on October 7, 2014)
- Proteon Therapeutics, Inc. 200 West St. Waltham, MA 02451 October 1, 2014 (Filed With SEC on October 7, 2014)
- FORM OF AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on October 7, 2014)
- FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 16, 2014)
- SERIES D PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on September 16, 2014)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on September 16, 2014)
- Release of Claims (Filed With SEC on September 16, 2014)
- Exhibit A Form of Release of Claims (Filed With SEC on September 16, 2014)
- PROTEON THERAPEUTICS, INC. 200 West Street Waltham, MA 02451 (Filed With SEC on September 16, 2014)
- Process Development and Manufacturing Services Agreement by and between Proteon Therapeutics and Lonza Ltd (Filed With SEC on September 16, 2014)
- 200 WEST STREET WALTHAM, MASSACHUSETTS Lease dated July 13, 2009 (Filed With SEC on September 16, 2014)
- ASSIGNMENT OF RIGHTS/LICENSE AGREEMENT NIH Sponsored Invention (Filed With SEC on September 16, 2014)
- ASSIGNMENT OF PATENT (Filed With SEC on September 16, 2014)
- QUITCLAIM DEED (Filed With SEC on September 16, 2014)
- PROTEON THERAPEUTICS, INC. 2006 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION) (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 16, 2014)